A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa

African Health Sciences

Volumn 10, Issue 4, 2010, Pages 320-324

  Castelnuovo, B ^a  

^a MULAGO HOSPITAL   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ADULT; ADVERSE DRUG REACTION; AFRICA; AGE; ARTICLE; ATTITUDE TO ILLNESS; CONTROLLED STUDY; DRUG RESPONSE; FAMILY RELATION; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; REPEAT PROCEDURE; RISK FACTOR; SPUTUM SMEAR; SUPPORT GROUP; TREATMENT PLANNING; TUBERCULOSIS;

AFRICA SOUTH OF THE SAHARA; ANTITUBERCULAR AGENTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; PATIENT COMPLIANCE; RISK FACTORS; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; TUBERCULOSIS;

EID: 79952291078     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. GlobalHealthFact.org. Available at: http://www.globalhealthfacts.org/topic. [Accessed 1st of July 2009].
2. WHO (2005) WHO declares TB an emergency in Africa. Press release. Available at: http://www.who.int/mediacentre/news/releases/2005/africa_emergency/en/index.html (accessed 1 June 2009).
3. WHO (2007). Global tuberculosis controlsurveillance, planning, financing. Available at: http://www.who.int/tb/publications/global_report/2009/en/index.html. misctextAccessed July 15 2009/misctext
4. Borgdroff, Floyd K and Broekmans JF. Intervention to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bulletin on the World Health Organization 80, 217-227.
5. WHO 2003. Treatment of tuberculosis. Guidelines for national programs. Available at: http:// www.who.int/tb/publications/cds_tb_2003_313/en/index.html. Accessed July 15 2009.
6. Nuwaha, F. Control of tuberculosis in Uganda: a tale of two districts. Internal Journal of Tuberculosis and Lung Diseases 1999; 224-230.
7. Katabira C, Castelnuovo B, Bhushan A, Le E, Kambugu A, and Manabe Y. Examining Drug Default for Treatment of Tuberculosis in an Urban HIV Clinic in Uganda. Implementers meeting 2009. Windhoek, Namibia.[117]
8. Tekle B, Mariam DH, and Ali A. Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Internal Journal of Tuberculosis and Lung Diseases 2002; 573-579.
9. Shargie EB, and Lindtjorn, B. Determinants of treatment adherence among smear-positive tuberculosis patients in Southern Ethiopia. PLOS medicine 2007; 4: 280-287PubMed.
10. Kaona ADF, Tuba M, Siziya S, and Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health 2004; 4: 68.